Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
47.8%
% of PPH's 26 holdings also in IHE
27.5%
% of IHE's 41 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.2% | 23.4% | 13.2% |
|
JOHNSON & JOHNSON | 7.4% | 25.5% | 7.4% |
|
BRISTOL-MYERS SQUIBB CO | 4.6% | 4.8% | 4.6% |
|
PFIZER INC | 4.5% | 4.7% | 4.5% |
|
MERCK & CO. INC. | 4.8% | 4.3% | 4.3% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to IHE
|
ABBVIE INC | 7.6% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.6% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.6% |
 |
NOVARTIS AG-ADR | 5.4% |
 |
SANOFI-AVENTIS-ADR | 5.3% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 5.0% |
|
MCKESSON CORP | 5.0% |
|
CENCORA INC | 4.9% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.9% |
 |
TEVA PHARMACEUTICAL-SP ADR | 3.0% |
PPH Underweight Relative to IHE
|
JOHNSON & JOHNSON | -18.1% |
|
ELI LILLY & CO | -10.2% |
|
INTRA-CELLULAR THERAPIES INC | -4.7% |
|
ROYALTY PHARMA PLC CLASS A | -4.5% |
|
VIATRIS, INC. | -2.0% |
 |
JAZZ PHARMACEUTICALS PLC | -2.0% |
|
CORCEPT THERAPEUTICS INC | -1.9% |
|
AXSOME THERAPEUTICS, INC. | -1.8% |
|
PRESTIGE BRANDS HOLDINGS INC | -1.5% |
|
ELANCO ANIMAL HEALTH, INC. | -1.4% |